| Cat.No. | Name | Information |
|---|---|---|
| M4497 | Norisoboldine | Norisoboldine is an isoquinoline alkaloid which acts as an AhR agonist. |
| M7531 | AZD4635 | AZD4635 is a novel adenosine 2A receptor (A2AR) inhibitor with a Ki of 1.7 nM. |
| M7282 | SCH 58261 | SCH 58261 is a potent, highly selective A2A antagonist. |
| M2282 | CGS 21680 hydrochloride | CGS 21680 hydrochloride is an A2A adenosine receptor agonist with an Ki of 27 nM. |
| M10132 | Inosine | Inosine (Inosine) is an endogenous purine nucleoside produced by the catabolism of adenosine. It has immunomodulatory, neuroprotective effects. |
| M5211 | ZM241385 | ZM-241385 is a high affinity antagonist ligand selective for the adenosine A2A receptor. |
| M3228 | CGS 21680 | CGS 21680 is a selective adenosine receptor agonist for A2A and A3 with Ki of 15 ng/mL and 37 ng/mL, respectively. |
| M10191 | Vipadenant | Vipadenant, also known as BIIB014, CEB-4520, is a potent, selective and orally available adenosine A2A receptor antagonist with Ki of 1.3 nM. |
| M40661 | Adenosine receptor inhibitor 2 | Adenosine receptor inhibitor 2 is a potent adenosine receptor AR inhibitor with dual affinity for A1/A2A ARs with Ki values of 52.2 and 167 nM, respectively. |
| M40660 | Adenosine receptor antagonist 1 | Adenosine receptor antagonist 1 is a selective adenosine receptor A2aR antagonist with an IC50 value of 0.29 nM and a 14-fold higher selectivity for A2aR than for A2bR. |
| M40659 | hA2A/hCA XII modulator 1 | hA2A/hCA XII modulator 1 is a triazolopyrazine and a potent adenosine receptor hA2A antagonist, with Ki of 6.4 nM, 4.819 μM, and >30 μM for hA2AAR, hA1AR, and hA3AR, respectively. hA2A/hCA XII modulator 1 is a potent inhibitor of human carbonic anhydrase XII (hCA XII). In addition, hA2A/hCA XII modulator 1 is also a potent human carbonic anhydrase XII (hCA XII) inhibitor with Ki of 6.2 nM, 46 nM, 466 nM, 8.351 μM for hCA XII, hCA II, hCA IX, and hCA I, respectively, and can be used in cancer-related studies. |
| M40658 | A1AR antagonist 4 | A1AR antagonist 4 is a potent, selective adenosine receptor A1AR antagonist with a pIC50 of 5.51 and a pKi of 6.29. |
| M40657 | A1AR antagonist 5 | A1AR antagonist 5 is a potent, selective adenosine receptor A1AR antagonist with a pIC50 of 5.83 and a pKi of 6.11.1. |
| M40654 | LAS38096 | LAS38096 is a potent, selective adenosine receptor A2B antagonist with a Ki value of 17 nM. |
| M40653 | A2AR-antagonist-1 | A2AR-antagonist-1 is an orally active adenosine receptor A2AR antagonist with an IC50 value of 29 nM.A2AR-antagonist-1 is also a T-cell activator that acts by inhibiting immunosuppressive molecules (LAG-3 and TIM-3) and potentiating effector molecules (GZMB, IFNG and IL-2). It has antitumor activity and is metabolically stable in mouse liver microsomes. |
| M40652 | Adenosine receptor antagonist 2 | Adenosine receptor antagonist 2 is a potent, orally active and antitumor active adenosine receptor A2a/A2b antagonist with IC50 values of 1 nM and 3 nM, respectively. |
| M40651 | M1069 | M1069 is an orally active, potent, and selective adenosine receptor A2A/A2B antagonist, with more than 100-fold selectivity over A1 and A3 subtypes. In addition, M1069 is able to antagonize adenosine-induced immunosuppression and has antitumor activity, which can be used in solid tumor research. |
| M40650 | PORT-8 | PORT-8 is a dual inhibitor of adenosine receptors A2aR and A2bR and can be used in studies related to solid tumors. |
| M40649 | PORT-6 | PORT-6 is an adenosine receptor A2aR inhibitor that can be used in a variety of tumor-related studies. |
| M30980 | Xanthine amine congener | Xanthine amine congener is a non-selective adenosine receptor antagonist. Xanthine amine congener induces convulsions in mice. |
| M30970 | N-[(4-Aminophenyl)methyl]adenosine | N-[(4-Aminophenyl)methyl]adenosine is a adenosine receptor inhibitor, with Ki of 29 nM for Rat ecto-5′-Nucleotidase. IC50 value: 29.0 ± 1.7 nM (Ki) Target: Adenosine Receptor |
| M30772 | Trabodenoson | Trabodenoson (INO-8875), an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma. |
| M30714 | Sipagladenant | Sipagladenant (Compound I) is an orally active adenosine receptor A2A inverse agonist. Sipagladenant can be used in frontal lobe dysfunction research. |
| M30180 | ST 1535 | ST 1535 is a potent and orally active A2A adenosine receptor antagonist. ST 1535 shows antiparkinsonian activity and antitremorigenic effects. ST 1535 has the potential for the research of Parkinson’s disease. |
| M30066 | N6-Cyclopentyladenosine | N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively. |
| M30061 | Enprofylline | Enprofylline acts as a selective and competitive A2B receptor antagonist with the Ki of 7 μM. Enprofylline also acts as a phosphodiesterase inhibitor. Enprofylline can be used for the research of asthma, chronic obstructive pulmonary disease. |
| M30019 | UK-432097 | UK-432097 is a highly potent and selective A2AAR agonist with a pKi of 8.4 for human A2AAR. UK-432097 has anti-inflammatory and anti-aggregatory properties. UK-432097 has the potential for COPD (Chronic Obstructive Pulmonary Disease) research. |
| M29993 | N6-Cyclohexyladenosine | N6-Cyclohexyladenosine is a selective A1 receptor agonist (EC50 = 8.2 nM). IC50 value: 8.2 nM (EC50) Target: A1 receptor in vivo: N6-Cyclohexyladenosine exerts anticonvulsant effects and protects against neuronal death. CHA was also found to inhibit the pressor effects of lumbar sympathetic nerve stimulation in rats. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
